Insights

Cutting-edge Cell Programming Technology bit.bio is a pioneer in cell programming technology, offering an end-to-end platform for creating human cell types with unprecedented speed and precision. This technology provides a unique selling point for engaging with clients looking to accelerate research and drug discovery timelines.

Recent Product Launches and Showcases With recent launches of new product lines like ioTracker Cells and GFP ioMicroglia, bit.bio has been actively showcasing its innovations at prominent industry events. This presents a prime opportunity to engage with potential customers interested in cutting-edge cell programming solutions.

Successful Financing Round Having secured a $30 million financing round led by M&G Investments, bit.bio demonstrates financial stability and investor confidence. This financial backing can be leveraged as a strong point when engaging with clients seeking reliable and well-supported partners.

Strategic Hiring of Financial Expert The recent hiring of Obloj, a professional with two decades of experience in financial and investment sectors, reflects bit.bio's strategic focus on growth and industry expertise. This expertise can serve as a key advantage in attracting clients looking for a financially savvy partner.

Market Leadership in Cell Programming As a global leader in cell programming technology with established revenue and funding figures, bit.bio holds a strong market position. Leveraging this leadership status can help in positioning the company as a preferred choice for clients seeking innovative and reliable biotechnology solutions.

bit.bio Tech Stack

bit.bio uses 8 technology products and services including Google Analytics, WordPress, SAP, and more. Explore bit.bio's tech stack below.

  • Google Analytics
    Analytics
  • WordPress
    Content Management System
  • SAP
    Customer Relationship Management
  • jQuery Migrate
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Cisco Meraki
    Network Hardware
  • iOS
    Programming Languages
  • JavaScript
    Programming Languages

Media & News

bit.bio's Email Address Formats

bit.bio uses at least 1 format(s):
bit.bio Email FormatsExamplePercentage
First.Last@bit.bioJohn.Doe@bit.bio
68%
First@bit.bioJohn@bit.bio
22%
Last@bit.bioDoe@bit.bio
5%
FLast@bit.bioJDoe@bit.bio
5%

Frequently Asked Questions

Where is bit.bio's headquarters located?

Minus sign iconPlus sign icon
bit.bio's main headquarters is located at The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is bit.bio's official website and social media links?

Minus sign iconPlus sign icon
bit.bio's official website is bit.bio and has social profiles on LinkedIn.

How much revenue does bit.bio generate?

Minus sign iconPlus sign icon
As of January 2025, bit.bio's annual revenue reached $15M.

What is bit.bio's SIC code NAICS code?

Minus sign iconPlus sign icon
bit.bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does bit.bio have currently?

Minus sign iconPlus sign icon
As of January 2025, bit.bio has approximately 207 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: P. O.Chief Scientific Officer (svp): E. M.Head Of Sales, Emea: D. H.. Explore bit.bio's employee directory with LeadIQ.

What industry does bit.bio belong to?

Minus sign iconPlus sign icon
bit.bio operates in the Biotechnology Research industry.

What technology does bit.bio use?

Minus sign iconPlus sign icon
bit.bio's tech stack includes Google AnalyticsWordPressSAPjQuery MigrateMicrosoftCisco MerakiiOSJavaScript.

What is bit.bio's email format?

Minus sign iconPlus sign icon
bit.bio's email format typically follows the pattern of . Find more bit.bio email formats with LeadIQ.

How much funding has bit.bio raised to date?

Minus sign iconPlus sign icon
As of January 2025, bit.bio has raised $30M in funding. The last funding round occurred on Oct 16, 2024 for $30M.

When was bit.bio founded?

Minus sign iconPlus sign icon
bit.bio was founded in 2016.
bit.bio

bit.bio

Biotechnology ResearchCambridgeshire, United Kingdom201-500 Employees

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. 

We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines.

Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies.

To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision.

Collaboration is at the heart of bit.bio. Join us on our journey. 

For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks

Section iconCompany Overview

Headquarters
The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB
Website
bit.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $30M

    bit.bio has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Oct 16, 2024 in the amount of $30M.

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $30M

    bit.bio has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Oct 16, 2024 in the amount of $30M.

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.